Sellas Life Sciences Group Inc share price logo

Sellas Life Sciences Group Inc Share Price

NASDAQ: SLS

Small Cap

$1.68

(+-0.30%)

as on

Sellas Life Sciences Group Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $1.65
    $1.73
    downward going graph

    1.79%

    Downside

    2.98%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.77
    $2.27
    downward going graph

    54.05%

    Downside

    35.07%

    Upside

    downward going graph

Sellas Life Sciences Group Inc share price movements today

Previous Close
$1.68
Open
$1.69
Volume
2.4M
Day's Low - High
$1.65 - $1.73
52 Week Low - High
$0.77 - $2.27

Sellas Life Sciences Group Inc Historical Returns

1 Month Return
+ 3.07 %
3 Month Return
+ 4.35 %
1 Year Return
+ 29.23 %
3 Year Return
-40 %
5 Year Return
-23.64 %

Sellas Life Sciences Group Inc Stock Fundamentals & Key Indicators

Check Sellas Life Sciences Group Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$194.8M

EPS (TTM)

-0.2933

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.02

Industry PE ratio

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Sellas Life Sciences Group Inc Stock Valuation

Track how Sellas Life Sciences Group Inc P/E has moved over time to understand its valuation trends.

Sellas Life Sciences Group Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 16, 2025

Industry (0.00x)

September 16, 2025

Today (-2.02x)

September 16, 2025

Highest (-0.76x)

March 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -2.02x

Sellas Life Sciences Group Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sellas Life Sciences Group Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$194.8M-23.64%-2.020.00%
BUY$61.1B251.26%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.2B47.46%28.0931.86%
BUY$59.6B0.6%14.131.37%

Stock Returns calculator for Sellas Life Sciences Group Inc Stock including INR - Dollar returns

The Sellas Life Sciences Group Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Sellas Life Sciences Group Inc investment value today

Current value as on today

₹1,34,098

Returns

₹34,098

(+34.1%)

Returns from Sellas Life Sciences Group Inc Stock

₹29,231 (+29.23%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Sellas Life Sciences Group Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Sellas Life Sciences Group Inc. Average target price of $6.83

Sellas Life Sciences Group Inc Share Price Target

Get share price movements and forecasts by analysts on Sellas Life Sciences Group Inc.

What analysts predicted

75.4%UPSIDE

Target Price

$6.83

Current Price

$1.68

Analyzed by

7 Analysts

Target

$6.83

Sellas Life Sciences Group Inc target price $6.83, a slight upside of 75.4% compared to current price of $1.68. According to 7 analysts rating.

Sellas Life Sciences Group Inc Stock's Interest Amongst Investors

Search interest for Sellas Life Sciences Group Inc Stock has decreased by -6% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-6% versus previous 30 day period

Sellas Life Sciences Group Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
-
-
-
-
-
-
-
-
Operating Income
-11
-9
-9
-8
-9
-7
-7
-6
-6
-6
EBITDA
-11
-9
-9
-8
-9
-7
-7
-16
-6
-6
Interest Expense
0
0
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-11
-8
-9
-8
-9
-7
-7
-6
-5
-6
Income Tax Expense
0
0
-9
-8
-9
-7
-
9
-
-
Net Income
-11
-8
-9
-8
-9
-7
-7
-6
-5
-6
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Sellas Life Sciences Group Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
0
7
1
-
-
Gross Profit
0
0
-
-
-
0
7
0
-
-
Operating Income
-34
-15
-15
-31
-20
-16
-25
-41
-37
-31
EBITDA
-37
-15
-23
-33
0
26
-19
-31
0
-30
Interest Expense
0
3
0
0
0
0
4
0
-
-
Depreciation
-
-
-
-
-
0
-
-
-
-
Income Before Tax
-38
-17
-23
-29
-19
-16
-20
-41
-37
-30
Income Tax Expense
0
0
0
-1
0
0
0
0
-37
-
Net Income
-63
-23
-23
-27
-19
-16
-20
-41
-37
-30
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-881947.37%
-272.36%
-4130.10%
0.00%
0.00%

Sellas Life Sciences Group Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-8
-9
-8
-9
-7
-7
-6
-5
-6
Operating Cash Flow
-7
-6
-4
-10
-9
-7
-7
-9
-7
Investing Cash Flow
-2
-3
-
-
-
-
-
-
-
Financing Cash Flow
0
0
3
26
0
19
0
23
4
Change in Cash
-10
-9
-1
15
-9
11
-7
14
-3

Sellas Life Sciences Group Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-11
-23
-27
-19
-16
-20
-41
-37
-30
Operating Cash Flow
-44
-10
-30
-17
-10
-26
-23
-31
-35
Investing Cash Flow
-1
1
-
-4
-4
-4
-4
-5
-
Financing Cash Flow
34
5
23
19
38
12
24
22
46
Change in Cash
-11
-3
-7
1
28
-13
-4
-14
11

Global Institutional Holdings in Sellas Life Sciences Group Inc

Funds
Holdings
Anson Funds Management LP
7.6%
Vanguard Group Inc
2.85%
Geode Capital Management, LLC
0.82%
Susquehanna International Group, LLP
0.69%
BlackRock Inc
0.54%

Insights on Sellas Life Sciences Group Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 41.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 156.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SLS stock has moved down by -9.7%

About Sellas Life Sciences Group Inc

σellas life sciences is a healthcare-oriented global group of companies with a unique and innovative vision, which is ambitious, yet clear: to practice the medicine of tomorrow, today. in other words, we incorporate innovation throughout all our activities aiming at breakthroughs that will have a significant impact on the thinking and practicing of healthcare worldwide. our international team of acknowledged scientists, doctors and health professionals along with a seasoned and highly experienced pharmaceutical executive management form the core of σellas. we strive to improve patients' quality of life through developing and commercializing cutting-edge drugs, medical devices and innovative therapies.
OrganisationSellas Life Sciences Group Inc
Headquarters7 Times Square, New York, NY, United States, 10036
IndustryHealth Technology
CEODr. Angelos M. Stergiou M.D., ScD h.c.
E-voting on sharesClick here to vote

Key Management of Sellas Life Sciences Group Inc

Name

Title

Dr. Dragan Cicic M.D., MBA

Senior VP & Chief Development Officer

Ms. Stacy E. Yeung

VP of Legal Affairs, Head of Compliance & Corporate Secretary

Mr. Andrew Elnatan

Senior VP of Regulatory Affairs, CMC & Quality

Dr. Angelos M. Stergiou M.D., ScD h.c.

Founder, President, CEO & Director

Mr. John Thomas Burns CPA

Senior VP & CFO

FAQs

What is Sellas Life Sciences Group Inc share price today?

Sellas Life Sciences Group Inc share price today is $1.68 as on at the close of the market. Sellas Life Sciences Group Inc share today touched a day high of $1.73 and a low of $1.65.

What is the 52 week high and 52 week low for Sellas Life Sciences Group Inc share?

Sellas Life Sciences Group Inc share touched a 52 week high of $2.27 on and a 52 week low of $0.77 on . Sellas Life Sciences Group Inc stock price today i.e. is closed at $1.68,which is 25.96% down from its 52 week high and 117.62% up from its 52 week low.

What is Sellas Life Sciences Group Inc's market capitalisation today?

Sellas Life Sciences Group Inc market capitalisation is $0.00T as on .

How to invest in Sellas Life Sciences Group Inc Stock (SLS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Sellas Life Sciences Group Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sellas Life Sciences Group Inc Shares that will get you 0.8929 shares as per Sellas Life Sciences Group Inc share price of $1.68 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Sellas Life Sciences Group Inc Stock (SLS) from India?

Indian investors can start investing in Sellas Life Sciences Group Inc (SLS) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Sellas Life Sciences Group Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Sellas Life Sciences Group Inc share’s latest price of $1.68 as on September 17, 2025 at 1:29 am IST, you will get 5.9524 shares of Sellas Life Sciences Group Inc. Learn more about fractional shares .

What are the returns that Sellas Life Sciences Group Inc has given to Indian investors in the last 5 years?

Sellas Life Sciences Group Inc stock has given -23.64% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?